glp 1 agonists muscle loss Weight with GLP-1 medicines does not result in a disproportionate loss of mass or function in obese mice and humans: Cell Reports Medicine GLP-1 receptor agonists and muscle
Description
Incretin-Based Therapies: A Promising Approach for Modulating Oxidative Stress and Insulin Resistance in Sarcopenia
Kim TH, et al
Dr Sands said the finding that greater loop gain predicted treatment effectiveness was initially surprising
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 811 April 2024
Write them down on an index card or in your phone notes
